Skip to content

Clinical trials

Parkinson Disease trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Not applicable Country / region: United States Clear all

579 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20043
20053
20066
20078
20084
200910
20108
201111
201213
201323
201428
201526
201629
201732
201836
201942
202035
202152
202247
202335
202438
202539
202645

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed310
Recruiting98
Terminated46
Active, not recruiting35
Unknown status33
Enrolling by invitation20
Not yet recruiting19
Withdrawn16
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VA Office of Research and Development25
University of Florida24
University of Alabama at Birmingham17
University of Colorado, Denver17
Oregon Health and Science University16
Washington University School of Medicine14
Stanford University13
New York Institute of Technology12
University of Minnesota12
University of Miami11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease579
Movement Disorders26
Cognitive Dysfunction25
Parkinsonian Disorders20
Essential Tremor18
Multiple Sclerosis16
Stroke16
Nervous System Diseases14
Dementia13
Dystonia13

Trials

Showing 1 to 25 of 579. Each trial links to its page on Pharma Observatory.

479 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.